How these pharmaceuticals may affect otolaryngology
Articles tagged with "pharmaceuticals"
Balancing the risks and benefits of concurrent reirradiation and chemotherapy for recurrent head and neck cancers is difficult for physicians at even the most experienced centers. Research recently published in Cancer, however, suggests that selection of patients who may benefit from this therapy should be based on the patient’s previous treatment and the amount of time that has elapsed since initial treatment…
Otolaryngologists agree with their fellow physicians who prescribe drugs-pharmaceutical companies have no business buying or using information on how and when they prescribe particular drugs, nor do they want to be confronted by pharmaceutical company representatives in their office about why they do or don’t prescribe that company’s products.